...
首页> 外文期刊>Biosensors & Bioelectronics: The International Journal for the Professional Involved with Research, Technology and Applications of Biosensers and Related Devices >Ultrasensitive electrochemiluminescence immunoassay for simultaneous determination of CA125 and CA15-3 tumor markers based on PAMAM-sulfanilic acid-Ru(bpy)3 2+ and PAMAM-CdTe@CdS nanocomposite
【24h】

Ultrasensitive electrochemiluminescence immunoassay for simultaneous determination of CA125 and CA15-3 tumor markers based on PAMAM-sulfanilic acid-Ru(bpy)3 2+ and PAMAM-CdTe@CdS nanocomposite

机译:超敏感的电化学荧光免疫测定同时测定Ca125和Ca15-3基于Pamam-磺酸-Cu(BPY)的肿瘤标志物 3 2 + 和PAMAM-CDTE @ CD纳米复合材料

获取原文
获取原文并翻译 | 示例

摘要

Abstract A multiplex ultrasensitive electrochemiluminescence (ECL) immunoassay was developed for the simultaneous determination of two different tumor markers, cancer antigen 153 (CA 15-3) and cancer antigen 125 (CA 125) using polyamidoamine dendrimer-quantum dots (PAMAM-QDs) and PAMAM-sulfanilic acid-Ru(bpy)3 2+ as the signal probes and Fe3O4–SiO2 as a magnetic bead. The CdTe@CdS- QDs and Ru(bpy)3 2+ at the presence of tripropyl amine (TPA) as coreactant generate ECL at an applied voltage of + 1.2V (vs Ag/AgCl) in two different wavelengths 500 and 620nm, respectively. Based on this strategy, the simultaneous detection of two tumor markers in single run carried out. This dual signal amplification technique was achieved by employing Fe3O4@SiO2-dendrimer as immunosensing platform and PAMAM as the carrier for immobilizing CdTe@CdS and Ru(bpy)3 2+ probes. Experimental results illustrated that the designed immunosensor can be used to sequentially detection of CA 125 and CA 15-3 markers with the wide linear ranges of 1μU/mL to 1U/mL and 0.1mU/mL to 100U/mL with very low detection limits of 0.1μU/mL and 10μU/mL, respectively. The application
机译:<![cdata [ 抽象 开发了多重超声电化学荧光(ECL)免疫测定,用于同时测定两种不同的肿瘤标志物,癌抗原153(CA 15-3)和癌症抗原125(CA 125)使用聚酰胺胺树枝状纤维 - 量子点(PAMAM-QDS)和PAMAM-磺酸酸-RU(BPY) 3 2 + 作为信号探测器和FE 3 O 4 -SIO 2 作为磁珠。 CDTE @ CDS- QD和Ru(BPY) 3 2 + 在存在时Tripro戊胺(TPA)作为固件在两个不同波长500和620中的施加电压的施加电压以+ 1.2 025“/> v(Vs Ag / AgCl)的施加电压产生ECL。 />纳米分别。基于该策略,同时检测单次营路中的两种肿瘤标志物。这种双信号放大技术是通过使用FE 3 O 4 @SIO 2 -dendrimer作为免疫抑制平台和pamam作为固定CDTE @ CD和Ru(BPY) 3 2 + 探针。实验结果表明,设计的免疫传感器可用于顺序地检测Ca 125和Ca 15-3标记,其宽的线性范围为1 μu/ ml至1 U / mL和0.1 mu / ml至100 U / ml,具有0.1 μu/ ml和10 μu/ ml。应用程序

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号